BMY Stock Recent News

BMY LATEST HEADLINES

BMY Stock News Image - zacks.com

BMY loses 16.3% YTD as pipeline setbacks and generic pressure offset gains from new drug approvals and sales.

zacks.com 2025 Jun 30
BMY Stock News Image - 247wallst.com

Investors love dividend stocks, especially the blue-chip variety, because they offer a significant income stream and have massive total return potential.

247wallst.com 2025 Jun 30
BMY Stock News Image - seekingalpha.com

Bristol-Myers Squibb faces structural headwinds from legacy product losses, but its strong free cash flow and undervalued stock price provide downside protection. The recent $11B partnership with BioNTech signals management's ambition to revitalize growth and address long-term potential in oncology. Despite near-term 'dead money' concerns, BMY's deeply discounted valuation, while paying more than 5% in dividend yield offers an attractive margin of safety.

seekingalpha.com 2025 Jun 29
BMY Stock News Image - 247wallst.com

Investors love dividend stocks, especially high-yield ones, because they offer a significant income stream and have substantial total return potential.

247wallst.com 2025 Jun 28
BMY Stock News Image - businesswire.com

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Abecma--U.S. FDA Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy Labels.

businesswire.com 2025 Jun 26
BMY Stock News Image - 247wallst.com

For income investors seeking a timely value stock to buy on the dip, former dividend darling Bristol-Myers Squibb (NYSE:BMY) may fit the bill as one of the top names to watch in the month of July.

247wallst.com 2025 Jun 26
BMY Stock News Image - zacks.com

BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.

zacks.com 2025 Jun 25
BMY Stock News Image - reuters.com

Cigna sued Bristol Myers on Tuesday, accusing the drugmaker of violating federal antitrust law by maintaining a monopoly over a blockbuster multiple myeloma drug sold under the brand name Pomalyst.

reuters.com 2025 Jun 24
BMY Stock News Image - seekingalpha.com

Long-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge dividends. They should be a better bet than treasuries.” — Barron's Weekly. In Barron's, Steven Wieting, strategist at Citi Wealth, noted that a growing dividend is a tangible benefit for shareholders and a hallmark of companies with strong balance sheets. "Nobody can fake a dividend," he said.

seekingalpha.com 2025 Jun 24
BMY Stock News Image - zacks.com

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

zacks.com 2025 Jun 24
10 of 50